Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- VISTN.OL
- Price
- 23.70
- Stock movement down
- -0.50 (-2.07%)
- Company name
- Vistin Pharma ASA
- Exchange
- (OL ,
- Currency
- NOK )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Markedsværdi
- 1.05B
- Ent værdi
- 1.12B
- Pris/omsætning
- 2.48
- Pris/bog
- 3.38
- Udbytte afkast
- -
- Udbyttevækst
- -
- Vekst år
- -
- FCF-udbetaling
- 99.36%
- Efterfølgende P/E
- 17.13
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års afkast
- 1.72%
- 3 års afkast
- 10.64%
- 5 års afkast
- 26.91%
- 10 års afkast
- -
Senest opdateret: 2025-04-04
UDBYTTE
VISTN.OL betaler ikke udbytte
VÆRDIANSÆTTELSE
Værdiansættelsesforhold
Loading...
Værdiansættelsesforhold-data
| Efterfølgende P/E | 17.13 |
| Pris til OCF | 10.52 |
| Pris til FCF | 18.84 |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Værdiansættelse (salg/bogført værdi)
Loading...
Værdiansættelse (salg/bogført værdi)-data
| Pris til omsætning | 2.48 |
| Pris til egenkapital | 3.38 |
| EV i forhold til salg | 2.65 |
ØKONOMI
Pr. aktie
Loading...
Data pr. aktie
| Aktuelt antal aktier | 44.34M |
| EPS (TTM) | 1.38 |
| FCF pr. aktie (TTM) | 1.26 |
Resultatopgørelse
Loading...
Resultatopgørelse-data
| Omsætning (TTM) | 423.59M |
| Bruttofortjeneste (TTM) | 218.13M |
| Driftsindkomst (TTM) | 82.67M |
| Nettoindkomst (TTM) | 61.37M |
| EPS (TTM) | 1.38 |
| EPS (1 år frem) | - |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | 51.50% |
| Driftsmargin (TTM) | 19.52% |
| Fortjenstmargin (TTM) | 14.49% |
Balance
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
| Kontanter | 5.63M |
| Nettotilgodehavender | 61.28M |
| Omsætningsaktiver i alt | 143.82M |
| Goodwill | 0.00 |
| Immaterielle aktiver | 0.00 |
| Ejendomme, anlæg og udstyr | 0.00 |
| Sum aktiver | 387.94M |
| Kreditor | 18.30M |
| Kortfristet/nuværende langsigtet gæld | 0.00 |
| Summen af kortfristede forpligtelser | 67.40M |
| Sum gæld | 77.20M |
| Aktionærernes egenkapital | 310.74M |
| Materielle nettoaktiver | 0.00 |
Likviditet
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
| Likviditet fra driften (TTM) | 99.86M |
| Investeringsudgifter (TTM) | 44.09M |
| Fri pengestrøm (TTM) | 55.77M |
| Udbetalt udbytte (TTM) | 55.41M |
Finansiel indkomst
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
| Egenkapitalafkast | 19.75% |
| Afkast af aktiver | 15.82% |
| Afkast af investeret kapital | 19.75% |
| Kontant afkast af investeret kapital | 17.95% |
INFORMATION OM AKTIER
Aktiediagram
Loading...
Aktiekurs-data
| Åbning | 23.90 |
| Daglig høj | 23.90 |
| Daglig lav | 23.60 |
| Daglig volumen | 7K |
| Højeste gennem alle tider | 28.60 |
| 1 års analytiker estimat | - |
| Beta | 0.89 |
| EPS (TTM) | 1.38 |
| Udbytte pr. aktie | - |
| Ex-div dato | 6 Nov 2024 |
| Næste dato for resultatpræsentation | 22 Apr 2025 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| VISTN.OL | S&P500 | |
| Nuværende prisfald fra top notering | -17.13% | -12.44% |
| Højeste prisfald | -82.27% | -56.47% |
| Højeste efterår dato | 16 Mar 2020 | 9 Mar 2009 |
| Gennemsnitlig fald fra toppen | -35.24% | -11.07% |
| Gennemsnitlig tid til nyt højdepunkt | 116 days | 12 days |
| Maks. tid til nyt højdepunkt | 2009 days | 1805 days |
OPLYSNINGER OM VIRKSOMHEDEN
Markedsværdi
1.05B
Markedsværdi kategori
Small-cap
Beskrivelse
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Personale
73
Hjemmeside
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
Norway
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
Oslo, Norway, 13th of February 2025 Vistin Pharma ASA (VISTN) today announces the financial results for the fourth quarter and preliminary results of 2024. Revenue in the fourth quarter ended at MNOK ...
13. februar 2025
Oslo, Norway, 6 February 2025 Vistin Pharma ASA will release its fourth quarter and preliminary 2024 results on Thursday 13th of February 2025. Vistin Pharma will host a conference call for all shareh...
6. februar 2025
Oslo, Norway, 31st of October 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the third quarter of 2024. Revenue in the third quarter ended at MNOK 106 compared to MNOK 120 in...
31. oktober 2024
Oslo, Norway, 24 October 2024 Vistin Pharma ASA will release its third quarter and YTD 2024 results on Thursday 31st of October 2024. Vistin Pharma will host a conference call for all shareholders and...
24. oktober 2024
Oslo, Norway, 23rd of August 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the second quarter of 2024. Revenue in the second quarter ended at MNOK 106 compared to MNOK 107 i...
23. august 2024
Oslo, Norway, 16 August 2024 Vistin Pharma ASA will release its second quarter and YTD 2024 results on Friday 23rd of August 2024. Vistin Pharma will host a conference call for all shareholders and in...
16. august 2024
Oslo, Norway, 23 May 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the minutes from the annual general meeting held today, on the 23 May 2024. All matters were resolved as proposed in the ...
23. maj 2024
Oslo, Norway, 30 April 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 23 May 2024 at 13:00 CEST. A physical Annual Ge...
30. april 2024
Oslo, Norway, 24th of April 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2024. Revenue in the first quarter ended at MNOK 104 compared to MNOK 101 in Q...
24. april 2024
Oslo, Norway, 16 April 2024 Vistin Pharma ASA will release its first quarter results on Wednesday 24th of April 2024. Vistin Pharma will host a conference call for all shareholders and interested part...
16. april 2024